Neovasc (NVC) Set to Announce Earnings on Thursday

Neovasc (TSE:NVCGet Rating) (NASDAQ:NVCN) is scheduled to be releasing its earnings data after the market closes on Thursday, August 11th. Analysts expect Neovasc to post earnings of C($1.50) per share for the quarter.

Neovasc (TSE:NVCGet Rating) (NASDAQ:NVCN) last released its quarterly earnings results on Thursday, May 12th. The company reported C($3.81) EPS for the quarter, missing the consensus estimate of C($1.50) by C($2.31). The company had revenue of C$0.77 million during the quarter, compared to analyst estimates of C$1.02 million.

Neovasc Price Performance

Neovasc has a one year low of C$0.49 and a one year high of C$6.07. The company has a 50 day moving average of C$1.78.

Insider Activity

In related news, Director Paul Geyer sold 4,933 shares of the stock in a transaction that occurred on Wednesday, June 8th. The stock was sold at an average price of C$7.20, for a total value of C$35,517.60. Over the last ninety days, insiders purchased 8,277 shares of company stock valued at $63,682 and sold 6,287 shares valued at $44,751.

Neovasc Company Profile

(Get Rating)

Neovasc Inc (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company’s segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products.

Featured Articles

Earnings History for Neovasc (TSE:NVC)

Want More Great Investing Ideas?

Receive News & Ratings for Neovasc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neovasc and related companies with MarketBeat.com's FREE daily email newsletter.